Karen Midthun

Developing the Nation's Biosimilars Program

Steven Kozlowski, Janet Woodcock, Karen Midthun et al. · New England Journal of Medicine · 2011 · 196 citations

Pharmacy, Pharmaceutical Policy, Drug Approval Processes +15

The Safety and Immunogenicity of a Human Immunodeficiency Virus Type 1 (HIV-1) Recombinant gp160 Candidate Vaccine in Humans

Raphael Dolin, Barney S. Graham, Stephen B. Greenberg et al. · Annals of Internal Medicine · 1991 · 169 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Comparison of the amino acid sequences of the major neutralization protein of four human rotavirus serotypes

Kim Y. Green, Karen Midthun, M Gorziglia et al. · Virology · 1987 · 133 citations

Life Sciences, Microbiology, Molecular Biology +10

The US Food and Drug Administration's Sentinel Initiative: Expanding the horizons of medical product safety

Melissa A. Robb, Judith A. Racoosin, Rachel E. Sherman et al. · Pharmacoepidemiology and Drug Safety · 2012 · 121 citations · Full text

Pharmacy, Pharmaceutical Policy, Food Safety +16

The Food and Drug Administration's Post‐Licensure Rapid Immunization Safety Monitoring program: strengthening the federal vaccine safety enterprise

Michael Nguyen, Robert Ball, Karen Midthun et al. · Pharmacoepidemiology and Drug Safety · 2012 · 104 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17